MYLAN DA 15 MYLAN DA 15 Pill - brown & white capsule/oblong, 18mm
Pill with imprint MYLAN DA 15 MYLAN DA 15 is Brown & White, Capsule/Oblong and has been identified as Dextroamphetamine Sulfate Extended-Release 15 mg. It is supplied by Mylan Pharmaceuticals Inc.
Dextroamphetamine is used in the treatment of ADHD; Narcolepsy and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Dextroamphetamine 15 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Images for MYLAN DA 15 MYLAN DA 15
Dextroamphetamine Sulfate Extended-Release
- Imprint
- MYLAN DA 15 MYLAN DA 15
- Strength
- 15 mg
- Color
- Brown & White
- Size
- 18.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- CNS stimulants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 2 - High potential for abuse
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC)
- 00378-1072 (Discontinued)
- Inactive Ingredients
-
ferrosoferric oxide,
corn starch,
hypromelloses,
ferric oxide red,
sodium lauryl sulfate,
sucrose,
magnesium silicate,
titanium dioxide,
ferric oxide yellow,
ammonia,
propylene glycol,
shellac
Note: Inactive ingredients may vary.
More about dextroamphetamine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (292)
- Drug images
- Latest FDA alerts (3)
- Side effects
- Dosage information
- During pregnancy
- Support group
- Drug class: CNS stimulants
- Breastfeeding
- En español
Patient resources
- Dextroamphetamine drug information
- Dextroamphetamine Tablets
- Dextroamphetamine Sustained-Release Capsules
- Dextroamphetamine Oral Solution
Other brands
Dexedrine, Xelstrym, Zenzedi, Dextrostat, ... +2 more
Professional resources
- Dextroamphetamine monograph
- Dextroamphetamine (FDA)
- Dextroamphetamine ER (FDA)
- Dextroamphetamine Extended-Release Capsules (FDA)
- Dextroamphetamine Oral Solution (FDA)
Other brands
Dexedrine, Xelstrym, Zenzedi, Dextrostat, ProCentra
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.